MONTREAL, QUEBEC--(MARKET WIRE)--Jun 22, 2006 -- ART Advanced Research Technologies Inc. ("ART") (TSX:ARA.TO - News), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, is pleased to announce that it has filed a Medical Device Licence Application with Health Canada to begin the commercialization of its SoftScan breast imaging device. The granting of a licence will allow ART to distribute the SoftScan device in Canada by certifying that the device is safe and effective and meets quality standards.
